OBJECTIVE	We compared the efficacy , safety , and immunogenicity of a rhesus rotavirus tetravalent vaccine ( RRV-TV ) , a rhesus rotavirus monovalent ( serotype 1 ) vaccine ( RRV-S1 ) , and placebo in healthy American Indian infants for two rotavirus seasons .\